Antiphospholipid antibodies (aPL), such as anti-β2-glycoprotein I and anti-cardiolipin, can be transiently present in various infections, including hepatitis C and HIV, and have recently been identified in COVID-19 cases. The gene discussed is FASLG; the disease is COVID-19.